End-to-End CRDMO Platform
for oligonucleotide and peptide Therapeutics
global platform one vision v2 Homepage

About Us

WuXi TIDES has over 1,000 scientists from 10 R&D and manufacturing sites, offering discovery compound synthesis, process development and manufacturing of novel monomers, linkers and ligands, oligonucleotides, peptides and complex synthetic conjugates at any scale. Beyond chemistry, we offer formulation development, manufacturing, packaging, labeling and distribution in a variety of oral & injectable dosage forms and filling formats. Our comprehensive analytical method development, validation and testing platform supports your TIDES drug development from discovery through clinical to commercial. Moreover, our Regulatory Affairs CMC teams are experienced in preparing CMC dossiers of TIDES molecules to support global filings with all major regulatory agencies.

What's New?

Expansion
2024
Peptide
3D Video
Oligonucleotide
Case Study
Oligonucleotide
3D Video

How can we help?

Small Molecule Projects?

Copyright © 2024 WuXi TIDES

Scroll to Top
Please enable JavaScript in your browser to complete this form.
Checkboxes